Post-approval studies (Phase 4)Study completedNCT04522739
What this trial is testing
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Emory University 25